About AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) AREXVY contains recombinant RSV glycoprotein F stabilized in the prefusion conformation (RSVPreF3). This antigen is combined with GSK ...

Respiratory virus data included in the interactive data application is up-to-date as of April 19, 2025. Among its new features, the dashboard now includes RSV Severe Outcomes data.

A virus stock with a previously determined titer ... After further incubation in the incubator for 60 hours, the results were assessed by observing cytopathic effects, and images were captured using ...

In Maine, mosquitoes can spread EEE, Jamestown Canyon virus (JCV), and West Nile virus (WNV). Influenza, COVID-19, and respiratory syncytial virus (RSV) are three viral respiratory infections that ...

Respiratory motion in abdominal targets can affect BH precision and completeness. This study compares two motion mitigation strategies based on pulse/echo US motion tracking: robotic arm-based ...

The RSV immunization campaign ended on April 1, 2025. Respiratory syncytial virus (RSV) immunization for babies consists of the administration of a preventive treatment to eligible children. The ...

Enanta’s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting ...

Enanta’s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key ...

has issued a decision amending the marketing authorization for ABRYSVO ®, the company’s bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) vaccine, to extend the indication to ...